ArticleBMC cancer2022

Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patients.

Apostolos Tsiachristas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.